美亚光电（002690）：点评报告：色选机增长态势良好，医疗业务有所承压

Investment Rating - The report maintains a "Buy" rating for the company, expecting a relative performance increase of over 15% against the benchmark index in the next 6 to 12 months [11] Core Views - The company has shown a good growth trend in its color sorting machine business, while its medical segment has faced pressure due to market conditions [3][7] - The company achieved a revenue of 2.311 billion yuan in 2024, a year-on-year decrease of 4.73%, and a net profit of 649 million yuan, down 12.84% year-on-year [3] - The color sorting machine business continues to grow, with a revenue increase of 9.87% to 1.622 billion yuan, while the medical business saw a significant decline of 33.43% in revenue [7][8] Summary by Sections Financial Performance - In 2024, the company reported a total revenue of 2.311 billion yuan, with a year-on-year growth rate of -4.73% and a net profit of 649 million yuan, reflecting a -12.84% change [3] - The fourth quarter of 2024 saw a revenue of 733 million yuan, down 4.61% year-on-year but up 13.13% quarter-on-quarter [5] - The gross profit margin for 2024 was 50.43%, a decrease of 1.06 percentage points year-on-year, while the net profit margin was 28.09%, down 2.62 percentage points [5] Business Segments - The color sorting machine segment achieved a revenue of 1.622 billion yuan, with a gross margin of 49.64%, showing a year-on-year increase [7] - The medical segment's revenue fell to 503 million yuan, with a gross margin of 48.44%, reflecting a decline due to increased competition and sluggish demand [8] Market Outlook - The report indicates that the color sorting machine market is expected to continue its stable growth due to increasing digitalization and automation trends [7] - Despite the current challenges in the medical segment, the long-term potential remains strong, particularly in the dental CBCT market, which is expected to recover as the economy improves [8] Research and Development - The company invested 160 million yuan in R&D in 2024, representing 6.90% of its revenue, with a year-on-year increase of 7.29% [6] - The company holds 158 valid invention patents, enhancing its competitive edge in the market [6]